<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Actilyse; Alteplase" /><meta name="IX" content="Actilyse; Alteplase" /><title>Actilyse®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP1577-actilyse.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP1577-actilyse.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP1577-actilyse.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP747-cardiovascular-system.htm">2 Cardiovascular system</a> &gt; <a href="PHP1559-stable-angina-acute-coronary-syndromes-and-fibrinolysis.htm">2.10 Stable angina, acute coronary syndromes, and fibrinolysis</a> &gt; <a href="PHP1569-fibrinolytic-drugs.htm">2.10.2 Fibrinolytic drugs</a> &gt; <a href="PHP1576-alteplase.htm">ALTEPLASE(rt-PA, tissue-type plasminogen activator)</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP1569-fibrinolytic-drugs.htm" title="Previous: 2.10.2 Fibrinolytic drugs">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP1580-reteplase.htm" title="Next: RETEPLASE">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a389001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Alteplase</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Blood Formation, Coagulation, and Thrombosis 20:00 &gt; Antithrombotic Agents 20:12 &gt; Thrombolytic Agents 20:12.20</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/16956-z.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Alteplase</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: A &gt; Interactions of Alteplase</p></div></li></ul><ul><li><h3>British National Formulary (3)</h3></li><li><a href="PHP1569-fibrinolytic-drugs.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">2.10.2 Fibrinolytic drugs</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.10 Stable angina, acute coronary syndromes, and fibrinolysis</p></div></li><li><a href="PHP1576-alteplase.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ALTEPLASE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.10 Stable angina, acute coronary syndromes, and fibrinolysis &gt; 2.10.2 Fibrinolytic drugs</p></div></li><li><a href="PHP9312-alteplase.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Alteplase</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Appendix 4 Intravenous additives &gt; Use of table &gt; Table of drugs given by intravenous infusion</p></div></li></ul><ul><li><h3>BNF for Children (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11756-alteplase.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ALTEPLASE</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.10 Myocardial infarction and fibrinolysis &gt; 2.10.2 Fibrinolytic drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11757-actilyse.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Actilyse®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.10 Myocardial infarction and fibrinolysis &gt; 2.10.2 Fibrinolytic drugs &gt; ALTEPLASE</p></div></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0066.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Alteplase</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; A</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a591001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Alteplase</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; A</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/A10-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Alteplase (recombinant tissue-type plasminogen activator, rt-PA, TPA)</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; A</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/16956-z.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Alteplase</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-A54.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Alteplase (Recombinant)</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; A</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E16E3E0R0D928.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Alteplase</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; A</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>ALTEPLASE<span class="cAB"><strong>(rt-PA, tissue-type plasminogen activator)</strong></span></h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">acute myocardial infarction (see notes above and <a title=" Management of myocardial infarction" href="PHP1560-management-of-stable-angina-and-acute-coronary-syndromes.htm">section 2.10.1</a>); pulmonary embolism; acute ischaemic stroke (treatment under specialist neurology physician <strong>only</strong>); thrombolytic treatment of occluded central venous access devices (including those used for haemodialysis)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see <a title="target-block: Fibrinolytic drugs cautions" href="PHP1569-fibrinolytic-drugs.htm#PHP1570">notes above</a>; <em>in acute stroke</em>, monitor for intracranial haemorrhage, monitor blood pressure (antihypertensive recommended if systolic above 180 mmHg or diastolic above 105 mmHg)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">see <a title="target-block: Fibrinolytic drugs contra-indications" href="PHP1569-fibrinolytic-drugs.htm#PHP1571">notes above</a>; <em>in acute stroke</em>, convulsion accompanying stroke, severe stroke, history of stroke in patients with diabetes, stroke in last 3 months, hypoglycaemia, hyperglycaemia</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">see <a title="BNF:target-block: hepatic fibrinolytic drugs" href="PHP1569-fibrinolytic-drugs.htm#PHP1573">notes above</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">see <a title="BNF:target-block: pregnancy fibrinolytic drugs" href="PHP1569-fibrinolytic-drugs.htm#PHP1574">notes above</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">see <a title="target-block: Fibrinolytics side-effects" href="PHP1569-fibrinolytic-drugs.htm#PHP1575">notes above</a>; also risk of cerebral bleeding increased in acute stroke</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>See under preparations below</p></li> </ul></div></div> </div><div id="pS"><p>Sub-sections</p><div id="PHP1577-actilyse" style="margin: 0 0 0 20px;"><h1 class="title">Actilyse® <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10070">Boehringer Ingelheim</a>)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Injection</strong>, powder for reconstitution, alteplase 10 mg (5.8 million units)/vial, net price per vial (with diluent) = £120.00; 20 mg (11.6 million units)/vial (with diluent and transfer device) = £180.00; 50 mg (29 million units)/vial (with diluent, transfer device, and infusion bag) = £300.00</p><p class="cR"><strong>Dose </strong>myocardial infarction, accelerated regimen (initiated within 6 hours of symptom onset), 15 mg <span class="cK">by intravenous injection</span>, followed <span class="cK">by intravenous infusion</span> of 50 mg over 30 minutes, then 35 mg over 60 minutes (total dose 100 mg over 90 minutes); in patients less than 65 kg, 15 mg <span class="cK">by intravenous injection</span>, followed <span class="cK">by intravenous infusion</span> of 0.75 mg/kg over 30 minutes, then 0.5 mg/kg over 60 minutes (max. total dose 100 mg over 90 minutes)</p><p class="cR">Myocardial infarction, initiated within 6–12 hours of symptom onset, 10 mg <span class="cK">by intravenous injection</span>, followed <span class="cK">by intravenous infusion</span> of 50 mg over 60 minutes, then 4 <span class="cK">infusions</span> each of 10 mg over 30 minutes (total dose 100 mg over 3 hours; max. 1.5 mg/kg in patients less than 65 kg)</p><p class="cR">Pulmonary embolism, 10 mg <span class="cK">by intravenous injection</span> over 1–2 minutes, followed <span class="cK">by intravenous infusion</span> of 90 mg over 2 hours; max. 1.5 mg/kg in patients less than 65 kg</p><p class="cR">Acute stroke (treatment <strong>must</strong> begin within 4.5 hours of symptom onset), <span class="cK">by intravenous administration</span> over 60 minutes, 900 micrograms/kg (max. 90 mg); initial 10% of dose by intravenous injection, remainder by intravenous infusion; <span class="cP">elderly</span> over 80 years not recommended</p></div></div><ul class="jT"><li><a href="PHP1578-actilyse-cathflo.htm#PHP1578-actilyse-cathflo" title="Actilyse Cathflo®">Actilyse Cathflo®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP1569-fibrinolytic-drugs.htm">Previous: 2.10.2 Fibrinolytic drugs</a> | <a class="top" href="PHP1577-actilyse.htm#">Top</a> | <a accesskey="]" href="PHP1580-reteplase.htm">Next: RETEPLASE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>